Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
...
Next
(12)
•••
LakeOromocto
X
View Profile
View Bullboard History
Comment by
LakeOromocto
on Jun 17, 2023 5:05pm
RE:RE:RE:RE:RE:RE:Don't waste time with individual license agreements for TFC1
I'm not an expert on social media but I don't believe it was marketed well. They could have used more key search words. Social Media is not blowing up over this. The question is how big is
...more
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Jun 17, 2023 3:50pm
RE:RE:RE:RE:RE:Don't waste time with individual license agreements for TFC1
The company certainly need some help in communication. I think you made an important observation that I would translate that the NR is very scientific oriented and not business oriented. If they say
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(2139)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 17, 2023 8:09am
RE:RE:RE:RE:Don't waste time with individual license agreements for TFC1
Sirona needs to make its news releases more stand alone. Don't assume readers have read every NR from the past. Stating that 1326 was discovered by studing polar fish does not increase a readers
...more
(10)
•••
PeterG
X
View Profile
View Bullboard History
Comment by
PeterG
on Jun 17, 2023 2:56am
RE:RE:RE:RE:RE:Don't waste time with individual license agreements for TFC1
Remember the publishing in a scientific journal with TFC-1067. It took more than a year. What's the issue to just post it right after the clinical Trial?? What the hell is management doing? We
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jun 16, 2023 9:20am
RE:RE:RE:RE:Don't waste time with individual license agreements for TFC1
The scientific results presented as such I would think are in hand from the clinical work and Geraldine's scientific research. It seems like they are being quite careful how this is distributed
...more
(10)
•••
PeterG
X
View Profile
View Bullboard History
Comment by
PeterG
on Jun 16, 2023 3:16am
RE:RE:RE:Don't waste time with individual license agreements for TFC1
https://www.mdpi.com/2079-9284/9/4/80 Guys, look at this study. Funded from Colgate -Palmolive and Filorga. Looks amazing so Sirona is not alone. This is how to present excellent data!!
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Jun 16, 2023 1:47am
RE:RE:Don't waste time with individual license agreements for TFC1
I'm sure that Geraldine will stay forever. She created the scientific platform that was sold to Sirona - it's her baby. Once upon a time she tried to convince the industry to let her (and the
...more
(10)
•••
PeterG
X
View Profile
View Bullboard History
Comment by
PeterG
on Jun 15, 2023 4:05pm
RE:Don't waste time with individual license agreements for TFC1
Could work, but again, there is a part time doctor leading a European science company. So we need to wait. My biggest fear is that Geraldine is frustrated as well and look after different
...more
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Jun 15, 2023 3:35pm
RE:Don't waste time with individual license agreements for TFC1
Tell them...
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Comment by
SleepyHoward
on Jun 15, 2023 11:47am
RE:RE:Don't waste time with individual license agreements for TFC1
A new ceo and we will see 20 cents without any news even if the new ceo called donald duck
(10)
•••
PeterG
X
View Profile
View Bullboard History
Comment by
PeterG
on Jun 15, 2023 11:19am
RE:Don't waste time with individual license agreements for TFC1
Can you see the smile in my face?? I just can see how Howard is reading your post. I hope that I'm still alive when Sirona is announcing a new CEO is stepping in. Finger's crossed. But with
...more
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Post by
Turtle4
on Jun 15, 2023 10:36am
Don't waste time with individual license agreements for TFC1
This is about costmetics and not about pharma, where license agreements are common. But for such a large cosmetics market, an exclusive license agreement is nonsense! Sirona should do the
...more
(10)
•••
PeterG
X
View Profile
View Bullboard History
Comment by
PeterG
on Jun 14, 2023 2:43pm
RE:HOPE ON THE HORIZON
I couldn't agree more. The worst thing here is that they know it and not correct it. I just wrote it in a German board. Howard is at a dignified age and if he wants to really let off steam
...more
(80)
•••
bealert
X
View Profile
View Bullboard History
Post by
bealert
on Jun 14, 2023 11:43am
HOPE ON THE HORIZON
Even though Chris wrote to supposedly only one shareholder, it's encouraging that the groundwork is being laid for a solid approach. Yes, it sucks that they didn't put out a news release
...more
Prev
...
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >